Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 5.50 ▲ 0.01 (0.18%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Catalyst Pharmaceuticals Inc | CPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.73% | 5.49 | 5.645 | 5.43 | 5.49 | 5.45 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.28 | 5.62 | 1.34 | 23.84% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,798 | 1,435,377 | $ 5.56 | $ 7,977,817 | 2,829,387 | 1.85 - 7.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:35:47 | 2 | $ 5.50 | USD |
Catalyst Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 565.08M | 102.93M | $ -34.00M | -0.34 | -11,058.35 | 93.76M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Catalyst Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.01 | 5.645 | 5.00 | 5.29 | 1,161,794 | 0.48 | 9.58% |
| 1 Month | 5.59 | 5.78 | 4.41 | 4.98 | 2,124,367 | -0.10 | -1.79% |
| 3 Months | 4.83 | 7.67 | 4.41 | 5.65 | 2,215,054 | 0.66 | 13.66% |
| 6 Months | 5.44 | 7.67 | 2.235 | 4.66 | 2,251,675 | 0.05 | 0.92% |
| 1 Year | 3.31 | 7.67 | 1.85 | 4.08 | 2,069,851 | 2.18 | 65.86% |
| 3 Years | 1.26 | 7.67 | 0.9414 | 3.46 | 1,233,904 | 4.23 | 335.71% |
| 5 Years | 2.50 | 7.67 | 0.51 | 3.13 | 1,062,134 | 2.99 | 119.6% |
Catalyst Pharmaceuticals Description
| Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome. |
